Skip to search formSkip to main contentSkip to account menu

MK-1597

Known as: ACT-178882 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
ACT-178882, a direct renin inhibitor, was used as a model compound in an elaborate drug–drug interaction study with atorvastatin… 
2013
2013
This study investigated the tolerability, safety, pharmacokinetics, and pharmacodynamics of ACT‐178882, a new direct renin… 
2013
2013
AIM To investigate the effect of age and sex on the single- and multiple-dose safety and pharmacokinetics of ACT-178882, a new… 
2013
2013
Background and ObjectiveThe cytochrome P450 (CYP) enzyme, CYP3A4, metabolizes ACT-178882, a new direct renin inhibitor. This… 
2010
2010
  • C. Veryard
  • 2010
  • Corpus ID: 29182006
The 111th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, held in Atlanta, included topics…